-
Impaired antibacterial autophagy links granulomatous intestinal inflammation in Niemann-Pick disease type C1 and XIAP deficiency with NOD2 variants in Crohn's disease.
Schwerd T. et al, (2017), Gut, 66, 1060 - 1073
-
Oncostatin M drives intestinal inflammation and predicts response to tumor necrosis factor-neutralizing therapy in patients with inflammatory bowel disease.
West NR. et al, (2017), Nat Med, 23, 579 - 589
-
Inflammatory cues enhance TGFβ activation by distinct subsets of human intestinal dendritic cells via integrin αvβ8.
Fenton TM. et al, (2017), Mucosal Immunol, 10, 624 - 634
-
Th1 and Innate Lymphoid Cells accumulate in Primary Sclerosing Cholangitis-associated Inflammatory Bowel Disease.
Gwela A. et al, (2017), J Crohns Colitis
-
Immune dysregulation in patients with PTEN hamartoma tumor syndrome: Analysis of FOXP3 regulatory T cells.
Chen HH. et al, (2017), J Allergy Clin Immunol, 139, 607 - 620.e15
-
Defining the microbial transcriptional response to colitis through integrated host and microbiome profiling.
Ilott NE. et al, (2016), ISME J, 10, 2389 - 2404
-
T-bet is a key modulator of IL-23-driven pathogenic CD4(+) T cell responses in the intestine.
Krausgruber T. et al, (2016), Nat Commun, 7
-
Integrative Phosphoproteomics Links IL-23R Signaling with Metabolic Adaptation in Lymphocytes.
Lochmatter C. et al, (2016), Sci Rep, 6
-
RORγt inhibitors suppress T(H)17 responses in inflammatory arthritis and inflammatory bowel disease.
de Wit J. et al, (2016), J Allergy Clin Immunol, 137, 960 - 963
-
CD161(int)CD8+ T cells: a novel population of highly functional, memory CD8+ T cells enriched within the gut.
Fergusson JR. et al, (2016), Mucosal Immunol, 9, 401 - 413